ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
TEMA ONCOLOGY ETF
41.65
-0.3620
-0.86%
盤後:
41.64
-0.0125
-0.03%
16:10 EDT
成交量:
1.85萬
成交額:
77.26萬
市值:
2.07億
市盈率:
- -
高:
42.15
開:
42.15
低:
41.43
收:
42.01
52周最高:
47.00
52周最低:
26.62
股本:
498.00萬
流通股本:
498.00萬
量比:
0.54
換手率:
0.37%
股息:
0.02
股息率:
0.05%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
隨着生物技術行業勢頭持續,Retension Pharmaceuticals和TRex Bio相繼提交美國IPO申請
路透中文
·
14小時前
美國食品藥品監督管理局批准禮來公司的一款乳腺癌聯合用藥方案
路透中文
·
17小時前
美國FDA批准Inluriyo(Imlunestrant)聯合Verzenio(Abemaciclib)用於治療ER陽性、HER2陰性、ESR1突變的晚期或轉移性乳腺癌成人患者
美股速递
·
19小時前
羅氏(RHHBY)重磅藥Ocrevus獲CHMP積極意見 擬在歐洲拓展兒科多發性硬化症適應症
金吾财讯
·
昨天
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/CANC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CANC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","market":"US","secType":"STK","nameCN":"TEMA ONCOLOGY ETF","latestPrice":41.6525,"timestamp":1789761600000,"preClose":42.0145,"halted":0,"volume":18510,"hourTrading":{"tag":"盘后","latestPrice":41.64,"preClose":41.6525,"latestTime":"16:10 EDT","volume":9,"amount":374.295,"timestamp":1789762204471,"change":-0.0125,"changeRate":-0.0003,"amplitude":0},"delay":0,"changeRate":-0.008616073022408806,"floatShares":4980000,"shares":4980000,"eps":0,"marketStatus":"休市中","change":-0.362,"latestTime":"09-18 16:00:00 EDT","open":42.15,"high":42.15,"low":41.43,"amount":772614,"amplitude":0.017137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1692158400000,"exchange":"NASDAQ","adjPreClose":42.0145,"sharesOutstanding":4310000,"nav":41.99,"aum":209110200,"dividendRate":0.000471,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.64,"preClose":41.6525,"latestTime":"16:10 EDT","volume":9,"amount":374.295,"timestamp":1789762204471,"change":-0.0125,"changeRate":-0.0003,"amplitude":0},"volumeRatio":0.540633688961473},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","floatShares":4980000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.540633688961473,"shares":4980000,"dividePrice":0.0196,"high":42.15,"amplitude":0.017137,"preClose":42.0145,"low":41.43,"week52Low":26.62,"pbRate":"--","week52High":47,"institutionHeld":0,"latestPrice":41.6525,"eps":0,"divideRate":0.000471,"volume":18510,"delay":0,"ttmEps":0,"open":42.15,"prevYearClose":34.7203,"prevWeekClose":41.5285,"prevMonthClose":43.3492,"prevQuarterClose":41.24,"fiveDayClose":41.5285,"twentyDayClose":44.0307,"sixtyDayClose":39.1725},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANC\",params:#limit:5,,,undefined,":[{"date":"2025-12-10","symbol":"CANC","amount":0.0195905,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-11","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-11"},{"date":"2024-12-11","symbol":"CANC","amount":0.72827,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"},{"date":"2023-12-13","symbol":"CANC","amount":0.149112,"announcedDate":"2023-12-12","type":"dividend","market":"US","newRecordDate":"2023-12-14","defaultRemindTime":1702477800000,"name":"TEMA ONCOLOGY ETF","recordDate":"2023-12-15","payableDate":"2023-12-14","currency":"USD","dateTimestamp":1702443600000,"payDate":"2023-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-13","recordDate":"2023-12-14","paymentDate":"2023-12-15","value":0.149112,"currency":"USD"},{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.72827,"currency":"USD"},{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-11","value":0.0195905,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668597668","title":"隨着生物技術行業勢頭持續,Retension Pharmaceuticals和TRex Bio相繼提交美國IPO申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2668597668","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668597668?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 06:35","pubTimestamp":1789770948,"startTime":"0","endTime":"0","summary":"更新版 1-随着生物技术行业势头持续,Retension Pharmaceuticals和TRex Bio相继提交美国IPO申请在第4、6-7段中补充了分析师评论路透9月18日-药物开发商Retension Pharmaceuticals和TRex Bio于上周五提交了在美国进行首次公开募股的申请文件,进一步充实了今年秋季IPO窗口期的生物技术项目储备。肯尼迪表示,鉴于Electra股价的下跌,生物科技公司的IPO将面临更严格的审查。Leerink Partners、古根海姆证券、奥本海默和Titan Partners是Retension此次发行的承销商。Retension和TRex将分别以股票代码“RTSN”和“TRXB”在纳斯达克上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4S45A1QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LLYZ","LU2089984988.USD","TREX","LU1061106388.HKD","LU0820562030.AUD","IE00BK4W5L77.USD","LU0096364046.USD","FHLC","GB00BDT5M118.USD","LU0354030438.USD","XLV","LU2236285917.USD","LU2237443895.HKD","LU2106854487.HKD","BK4086","LU1267930730.SGD","LU1023059063.AUD","LU2089284900.SGD","IE00BFSS8Q28.SGD","LU0266013472.USD","LU2168564065.EUR","LU0203201768.USD","SGXZ57979304.SGD","LU0385154629.USD","LU1057294990.SGD","LU2471134952.CNY","LU1868836757.USD","LU0122379950.USD","LU0114720955.EUR","LU0823416689.USD","PPH","LU1804176565.USD","IE00BN29S564.USD","LU0316494557.USD","LU2491050154.USD","BK4599","IE0001KFT4U8.USD","LU0109391861.USD","LU2168564495.EUR","ELIL","CURE","LU2896262040.SGD","CANC","LU2468319806.SGD","LU2211815571.USD","LU2361044865.SGD","IE00B2B36J28.USD","SGXZ51526630.SGD","IE00B4R5TH58.HKD","LU0640476718.USD","LU0354030511.USD","LU0320765992.SGD","LU1989771016.USD","LU0889565916.HKD","VHT","SG9999001176.SGD","IE00BJLML261.HKD","HRTS","LU2357305700.SGD","IE00B1BXHZ80.USD","LU0238689110.USD","IE00BFSS7M15.SGD","IXJ","LU0820561909.HKD","SGXZ99366536.SGD","LU2471134879.HKD","LU2491050071.SGD","LU2237438978.USD","LU2237443549.SGD","LU1323610961.USD","LU2602419157.SGD","LU0198837287.USD","IHE","IE00BK4W5M84.HKD","LU0106261372.USD","LU1868836914.USD","LU1988902786.USD","MHIP","LLYX","LU2089283258.USD","LU1868837300.USD","MEDX","LU0320765059.SGD","SG9999018865.SGD","TMED","LU2063271972.USD","BK4533","IE00B4JS1V06.HKD","LU0882574139.USD","LU0417517546.SGD","SG9999018857.SGD","SGXZ81514606.USD","LU1551013425.SGD","BK4588","LU0823434740.USD","LU0964807845.USD","SG9999017495.SGD","LU1280957306.USD","SGXZ31699556.SGD","LU0787776722.HKD","IE00BJJMRZ35.SGD","LU1366192091.USD","LU2417539215.USD","BK4516","LU2265009873.SGD","LU2461242641.AUD","LU2491049909.HKD","LU0689472784.USD","LU0006306889.USD","OZEM","SG9999015978.USD","SG9999014880.SGD","LU0471298777.SGD","LU2361045086.USD","IE00B775H168.HKD","LU2028103732.USD","LU2237443978.SGD","LU2756315318.SGD","LU1093756325.SGD","SG9999015945.SGD","SG9999015986.USD","LU2023250330.USD","LU2087625088.SGD","LU2361044949.HKD","LU1064131342.USD","IE00B7KXQ091.USD","LU2456880835.USD","LU2023250504.SGD","SG9999013999.USD","LU2360106947.USD","BK4007","LU1979441026.SGD","LU2746668461.USD","SG9999001176.USD","LU2213496289.HKD","LU2552382215.SGD","LU1035775433.USD","LU1623119135.USD","BK4581","LU2168563687.JPY","TRUH","THNR","LU2237443382.USD","LU2750360641.GBP","LU2462591350.SGD","SG9999015952.SGD","LU1720051017.SGD","LLII","LU0158827781.USD","SG9999014898.SGD","LU0094547139.USD","LU0820561818.USD","LU0256863902.USD","LU1814569148.SGD","LU2108987350.USD","LU2111349929.HKD","ETRA","RXL","IE0004445239.USD","LU1551013342.USD","LU0353189763.USD","LU2750360997.AUD","LU0234572021.USD","LU2112291526.USD","LU2756315664.SGD","LU0823434583.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2552382132.HKD","IE00BFTCPJ56.SGD","IE00BJJMRX11.SGD","LU0058720904.USD","LU2471134796.USD","ILDR","LU1712237335.SGD","LU1069344957.HKD","LU0432979614.USD","LU0079474960.USD","LU0471298694.HKD","IYH","LU0097036916.USD","LU0109394709.USD","LU1868837136.USD","LU0345770308.USD","ELIS","LU1691799644.USD","IE00B1XK9C88.USD","LU0158827948.USD","LU0174119429.USD","WDNA","LU1917777945.USD","LU2324357040.USD","PJP","LU0203202063.USD","IE0005OL40V9.USD","LU1145028129.USD","BK4585","LU0456855351.SGD","LU1629891620.HKD","LU1720051108.HKD","IE00BKDWB100.SGD","JDOC","LU2237443465.HKD","LU0466842654.USD","IE0004445015.USD","AGNG","LU1548497426.USD","LU1983299246.USD","LU2168564222.USD","LU2746668974.SGD","LU0225283273.USD","SG9999014906.USD","LU0133085943.USD","LU1093756168.USD","SG9999014914.USD","LU1232071149.USD","LU0061475181.USD","LU2462157665.USD","LU2264538146.SGD","LU2271345857.HKD","FTXH","LU2471134523.USD","LLY","GDOC","MEDI","LU0882574055.USD","LU2552382058.USD","LU0683600562.USD","LU0323591593.USD","LU1127390331.HKD","LU2023251221.USD","LU0786609619.USD","IE00BKPKM429.USD","LU0708995401.HKD","LU0256863811.USD","LU2237443622.USD","BK4534","LU0353189680.USD","LU0289739699.SGD","LU1291159041.SGD","LU1868836591.USD","LU0345770993.USD","LU2168564149.EUR","LU0943347566.SGD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU1974910355.USD","LU0210536198.USD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668592075","title":"美國食品藥品監督管理局批准禮來公司的一款乳腺癌聯合用藥方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2668592075","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668592075?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 03:11","pubTimestamp":1789758678,"startTime":"0","endTime":"0","summary":"礼来公司表示,约一半的雌激素受体阳性、HER2阴性转移性乳腺癌患者在接受一种广泛使用的激素阻断疗法治疗期间或之后会出现ESR1突变。美国食品药品监督管理局已于去年9月批准 的Inluriyo用于治疗转移性乳腺癌,即携带ESR1突变的IV期乳腺癌。该批准基于一项针对159名此类晚期乳腺癌患者的晚期临床研究。礼来公司表示,Inluriyo与Verzenio的联合用药方案即日起在美国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4S45A1I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2750360641.GBP","MEDI","SGXZ99366536.SGD","LU0345770993.USD","LU0345770308.USD","LU2264538146.SGD","MEDX","LU2491049909.HKD","LU0266013472.USD","LU0006306889.USD","SGXZ31699556.SGD","LU1629891620.HKD","LU2089984988.USD","LU2746668974.SGD","IE00B4R5TH58.HKD","LU0079474960.USD","LU1323610961.USD","IE00BN29S564.USD","LU2237443465.HKD","LU2023250504.SGD","SGXZ51526630.SGD","LU0820561818.USD","LU0109391861.USD","LU0471298694.HKD","LU0354030511.USD","LU0417517546.SGD","LU2106854487.HKD","LU2471134796.USD","GDOC","LU1868836757.USD","SG9999017495.SGD","LU0456855351.SGD","IE00BK4W5M84.HKD","SG9999018865.SGD","LU2271345857.HKD","SGXZ57979304.SGD","IXJ","BK4007","LLYZ","LU0109394709.USD","LU0158827948.USD","IE00BJJMRX11.SGD","IE00BJLML261.HKD","IHE","IE0002141913.USD","LU0823434583.USD","IE00B4JS1V06.HKD","LU2756315318.SGD","LU2168564495.EUR","LU0320765059.SGD","LU2361044949.HKD","LU2896262040.SGD","LU0203202063.USD","LU2237443978.SGD","LU0471298777.SGD","RXL","LU1989771016.USD","XLV","LU0323591593.USD","LU0097036916.USD","LU0210536198.USD","LU1712237335.SGD","LU1720051017.SGD","LU2468319806.SGD","BK4581","LU1974910355.USD","LU1979441026.SGD","LU2237443549.SGD","LU1145028129.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU1232071149.USD","LU0353189763.USD","LU1280957306.USD","LU2023251221.USD","LU2491050154.USD","SG9999001176.SGD","ELIS","LU1814569148.SGD","SG9999014898.SGD","LU2237443382.USD","IE00BK4W5L77.USD","BK4599","IE0004445015.USD","LU0640476718.USD","LU1868836591.USD","LU2063271972.USD","LU2471134952.CNY","LU2361044865.SGD","LU2108987350.USD","SG9999015952.SGD","LU2602419157.SGD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU1720051108.HKD","IE0005OL40V9.USD","LU2112291526.USD","LU2168564222.USD","LU2746668461.USD","IE00B7KXQ091.USD","LLII","LLY","LU0316494557.USD","TMED","SG9999015945.SGD","THNR","BK4533","IE00BJJMRY28.SGD","LU2471134523.USD","SG9999018857.SGD","LU0133085943.USD","LU0787776722.HKD","LU0354030438.USD","LU1551013342.USD","LU0114720955.EUR","LU0353189680.USD","LU2089284900.SGD","HRTS","WDNA","LU2168564065.EUR","LU0198837287.USD","LU2028103732.USD","CURE","LU2213496289.HKD","LU2357305700.SGD","LU0882574139.USD","LU1917777945.USD","IE00BKPKM429.USD","LU2491050071.SGD","OZEM","LU1127390331.HKD","LU2237443895.HKD","LU0234572021.USD","LU2236285917.USD","IE00B775H168.HKD","CANC","LU0256863811.USD","LU0158827781.USD","LU1868837136.USD","LU0225283273.USD","LU1291159041.SGD","LU1983299246.USD","MHIP","LU2168564149.EUR","AGNG","TRUH","LU0672654240.SGD","JDOC","LU1093756168.USD","LU0289739699.SGD","LU1267930730.SGD","LU2237438978.USD","IE0009355771.USD","LU0385154629.USD","LU2471134879.HKD","IE0001KFT4U8.USD","FTXH","LU0786609619.USD","LU1804176565.USD","LU0943347566.SGD","LU0061475181.USD","SG9999015978.USD","LU0466842654.USD","IE00B2B36J28.USD","LU2168563687.JPY","LU1988902786.USD","LU0122379950.USD","LU1064131342.USD","BK4534","LU2462591350.SGD","LU0708995401.HKD","LU1093756325.SGD","LU2023250330.USD","LU0096364046.USD","LU0203201768.USD","LU2361045086.USD","LU0094547139.USD","LU2462157665.USD","LU2756315664.SGD","SG9999015986.USD","SG9999013999.USD","LU0058720904.USD","LU2456880835.USD","LU1623119135.USD","LU2111349929.HKD","LU2211815571.USD","LU0683600562.USD","LU1868836914.USD","IYH","VHT","LU1548497426.USD","LU0238689110.USD","LU0964807845.USD","LU2552382058.USD","SG9999014906.USD","LU0823416689.USD","LU0320765992.SGD","PPH","SG9999014880.SGD","IE00BWXC8680.SGD","LU0174119429.USD","BK4516","SG9999001176.USD","LU2360106947.USD","LU2750360997.AUD","IE00BKDWB100.SGD","LU1023059063.AUD","GB00BDT5M118.USD","ILDR","LU0106261372.USD","LU0256863902.USD","LLYX","IE00B1XK9C88.USD","LU0689472784.USD","LU2265009873.SGD","LU1366192091.USD","LU2461242641.AUD","FHLC","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU2087625088.SGD","LU1035775433.USD","LU2417539215.USD","LU2552382132.HKD","SG9999014914.USD","LU1061106388.HKD","BK4585","LU0882574055.USD","LU2089283258.USD","LU0820562030.AUD","LU1551013425.SGD","LU1069344957.HKD","PJP","ELIL","SGXZ81514606.USD","LU1691799644.USD","LU1868837300.USD","LU2237443622.USD","BK4588","IE00BFSS8Q28.SGD","IE00BFTCPJ56.SGD","LU0820561909.HKD","LU2552382215.SGD","IE0004445239.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164434045","title":"美國FDA批准Inluriyo(Imlunestrant)聯合Verzenio(Abemaciclib)用於治療ER陽性、HER2陰性、ESR1突變的晚期或轉移性乳腺癌成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1164434045","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164434045?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 01:55","pubTimestamp":1789754137,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)已正式批准礼来公司(Eli Lilly)的Inluriyo(Imlunestrant)与Verzenio(Abemaciclib)联合用药方案,该方案适用于患有雌激素受体阳性(ER+)、人表皮生长因子受体2阴性(HER2-)且携带ESR1突变的晚期或转移性乳腺癌成人患者。这一批准标志着针对这一特定患者群体治疗选择的重要进展。值得注意的是,ESR1突变通常与内分泌治疗耐药相关,而此次获批的联合疗法或将为这类难治性患者提供新的治疗路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2111349929.HKD","LU0210536198.USD","LU1712237335.SGD","LU2746668461.USD","LU0198837287.USD","SG9999018857.SGD","XLV","IXJ","LU2023250330.USD","ELIS","CURE","LU1093756168.USD","IHE","LU0823416689.USD","LU2417539215.USD","BK4585","IE0009355771.USD","LU0114720955.EUR","LU0787776722.HKD","LU1691799644.USD","LU2089984988.USD","LLII","LU0820562030.AUD","LU2237443895.HKD","LU2756315318.SGD","LU2461242641.AUD","IE00BJJMRZ35.SGD","LU2089284900.SGD","IE0004445239.USD","LU1280957306.USD","LU0133085943.USD","LU1868836591.USD","IE00BJJMRY28.SGD","BK4581","IE0005OL40V9.USD","LU1623119135.USD","BK4588","LU0456855351.SGD","HRTS","SG9999015945.SGD","LU0353189680.USD","LU2237443549.SGD","IE0002141913.USD","LU0417517546.SGD","BK4533","SGXZ81514606.USD","LU2108987350.USD","LU2237443465.HKD","LU0964807845.USD","LU0889565916.HKD","LU1064131342.USD","LU2089283258.USD","LU0106261372.USD","LU0097036916.USD","LU1035775433.USD","IE00B7KXQ091.USD","LU2468319806.SGD","SGXZ57979304.SGD","LU1989771016.USD","IE00BK4W5M84.HKD","LU2237443978.SGD","IE00BJJMRX11.SGD","LU2750360641.GBP","LU0058720904.USD","LU2264538146.SGD","LU1814569148.SGD","LU2211815571.USD","VHT","LU0109394709.USD","FTXH","SG9999014898.SGD","LU1868837300.USD","IE00B2B36J28.USD","LU2462591350.SGD","LU1057294990.SGD","LU0385154629.USD","LU0943347566.SGD","LU1983299246.USD","LU0320765059.SGD","LU0203201768.USD","LU1979441026.SGD","LU0823434583.USD","LU0316494557.USD","LU1548497426.USD","GDOC","LU1551013425.SGD","IE00BKPKM429.USD","LU0256863902.USD","LU0882574055.USD","ILDR","LU0689472784.USD","LU2552382215.SGD","LU1061106388.HKD","LU2168564222.USD","LU2456880835.USD","IE00BFSS7M15.SGD","PPH","LU0683600562.USD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LLY","LU0786609619.USD","LU1232071149.USD","LU2023251221.USD","IE00B4R5TH58.HKD","LU1366192091.USD","LU0061475181.USD","LU0432979614.USD","LU0109391861.USD","LU2602419157.SGD","LU1974910355.USD","IE00BKDWB100.SGD","ELIL","LLYX","SG9999014880.SGD","LU2552382132.HKD","PJP","TRUH","CANC","LLYZ","IE00B4JS1V06.HKD","LU1093756325.SGD","SGXZ51526630.SGD","WDNA","LU2471134879.HKD","SG9999001176.USD","LU0289739699.SGD","LU1720051017.SGD","IYH","LU2750360997.AUD","LU2491049909.HKD","FHLC","IE00BJT1NW94.SGD","SG9999014906.USD","LU0158827781.USD","IE00BJLML261.HKD","MEDI","LU1868837136.USD","IE0001KFT4U8.USD","LU0471298694.HKD","THNR","LU0345770308.USD","LU0640476718.USD","RXL","LU2271345857.HKD","LU2168563687.JPY","LU2491050071.SGD","JDOC","BK4599","LU0266013472.USD","MHIP","SG9999013999.USD","LU0354030438.USD","LU0820561909.HKD","LU1868836757.USD","IE00BK4W5L77.USD","LU2746668974.SGD","SG9999001176.SGD","LU0345770993.USD","SG9999015952.SGD","LU2552382058.USD","LU1804176565.USD","LU1629891620.HKD","SG9999014914.USD","LU0079474960.USD","SGXZ31699556.SGD","LU0256863811.USD","LU0094547139.USD","LU0820561818.USD","LU2168564495.EUR","GB00BDT5M118.USD","LU2237438978.USD","LU2896262040.SGD","SG9999017495.SGD","LU1145028129.USD","LU2357305700.SGD","LU0708995401.HKD","LU1868836914.USD","LU0203202063.USD","LU0323591593.USD","LU2168564065.EUR","LU1127390331.HKD","LU2471134952.CNY","LU0353189763.USD","IE00B775H168.HKD","LU1551013342.USD","LU0225283273.USD","LU0122379950.USD","LU1917777945.USD","LU2168564149.EUR","LU0354030511.USD","LU1323610961.USD","LU0823434740.USD","LU2462157665.USD","LU2213496289.HKD","IE00BN29S564.USD","LU0174119429.USD","LU2106854487.HKD","AGNG","LU1267930730.SGD","LU0234572021.USD","LU2361045086.USD","IE00B1BXHZ80.USD","LU2237443382.USD","LU2471134523.USD","LU2491050154.USD","LU2324357040.USD","LU0238689110.USD","BK4007","LU2028103732.USD","MEDX","OZEM","TMED","LU1069344957.HKD","LU2087625088.SGD","LU1023059063.AUD","SG9999015986.USD","LU0096364046.USD","SG9999015978.USD","SG9999018865.SGD","LU1720051108.HKD","LU2756315664.SGD","IE00B1XK9C88.USD","BK4534","LU2360106947.USD","BK4516","LU0471298777.SGD","LU0158827948.USD","LU2361044949.HKD","LU2023250504.SGD","LU2265009873.SGD","LU1988902786.USD","LU1291159041.SGD","LU0466842654.USD","LU2361044865.SGD","LU2063271972.USD","IE0004445015.USD","LU0320765992.SGD","IE00BFSS8Q28.SGD","LU2237443622.USD","LU2236285917.USD","SGXZ99366536.SGD","LU2112291526.USD","LU0882574139.USD","LU2471134796.USD","LU0006306889.USD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492808","title":"羅氏(RHHBY)重磅藥Ocrevus獲CHMP積極意見 擬在歐洲拓展兒科多發性硬化症適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492808","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492808?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 19:30","pubTimestamp":1789731015,"startTime":"0","endTime":"0","summary":"金吾财讯 | 罗氏 获得欧洲药品管理局人用药品委员会积极审查意见,建议批准其旗下的抗CD20单克隆抗体药物Ocrevus,用于治疗10岁及以上儿童和青少年的复发型多发性硬化症。据介绍,继美国FDA于2026年5月批准该适应症后,若欧盟顺利获批,Ocrevus将成为欧洲首个面向10岁及以上儿科患者的高效抗CD20疗法,进一步巩固罗氏在神经科学及多发性硬化症治疗领域的市场领先地位。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306226","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHHBY","CANC","CHMP","BK4087","BK4007","HRTS","03165"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CANC\",params:#limit:6,delay:false,,,undefined,":[]}}